Physician profile
Ryan Mccomb
NPI 1669813952
$839.86
in general payments reported to CMS, 2019-2025
17 companies · $14.93 in 2025
The $14.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.33 · 2022: $30.27 · 2024: $753 · 2025: $14.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $768.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $198.85 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $169.60 | 2024 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $63.95 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $63.21 | 2024 | Rexulti |
| Dexcom, INC. | $44.52 | 2024-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $38.99 | 2021-2024 | Capvaxive, Gardasil 9, Gardasil |
| Glaxosmithkline, LLC. | $36.94 | 2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $33.01 | 2022-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.69 | 2024 | Jardiance |
| Axsome Therapeutics, INC. | $29.66 | 2024 | Auvelity |
| Phathom Pharmaceuticals, INC. | $28.79 | 2024 | Voquezna |
| Abbott Laboratories | $22.76 | 2024 | Freestyle Libre 2 |
| Exact Sciences Corporation | $16.76 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $16.24 | 2024 | |
| Amgen INC. | $15.94 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $15.54 | 2024 | |
| Azurity Pharmaceuticals, INC. | $14.41 | 2024 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Mccomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.